DOT Drug Testing Roles

What Is a DOT MRO?

The Medical Review Officer's Role in DOT Drug Testing — and Why the Collector's CCF Is the Foundation of Every Verified Result

Quick Answer — What Is a DOT MRO?

  • MRO = Medical Review Officer: a licensed physician (MD or DO) who receives laboratory results directly and verifies them before any report goes to the employer — authority defined in §40.121.
  • Verification role: the MRO reviews positive, substituted, adulterated, or invalid results and determines whether a legitimate medical explanation exists before reporting a final result to the employer.
  • Employee contact (§40.137): for any non-negative result, the MRO must contact the employee directly to conduct a medical interview — the employer is not present and does not direct this process.
  • Reports to the DER only: the MRO's final verified result goes to the Designated Employer Representative — never to the employee first, and never at the employer's direction (§40.129).
  • Separate from the collector: the MRO role under §40.121 is entirely distinct from the certified DOT urine collector role under §40.33. Collectors perform the physical collection; MROs review the laboratory result.
  • Required for all 6 DOT agencies: MRO review under 49 CFR Part 40 is mandatory across FMCSA, FRA, FAA, FTA, PHMSA, and USCG — no DOT modal agency is exempt.

When a CDL driver's drug test comes back non-negative, the lab result does not go directly to the trucking company. It goes to a Medical Review Officer — a federally qualified physician who reviews the result, contacts the employee, evaluates any medical explanations, and only then reports a final verified outcome to the employer. The MRO stands between the laboratory and the employer, acting as the scientific and legal gatekeeper of the drug testing process.

For HR directors, fleet safety managers, and CDL drivers navigating a test result, understanding the MRO's role clarifies why results take time, why employees are contacted before employers are notified, and why a collector error can derail an otherwise valid positive. For certified DOT collectors, understanding the MRO's process reveals exactly why CCF accuracy is not optional — it is the standard MROs enforce, and the standard collectors are trained to meet.

Why the MRO Matters

55M+
DOT-Regulated Employees

Every non-negative DOT drug test result — across all six modal agencies — flows through an MRO before the employer is notified. With over 55 million employees in safety-sensitive roles, MRO review is one of the most frequently exercised physician functions in American occupational medicine.

5
Result Categories — MRO Only

Only an MRO can issue a final verified DOT result. The five outcome categories — Negative, Positive, Substituted, Adulterated, and Invalid — are MRO determinations, not laboratory determinations. The lab reports what it found; the MRO decides what it means.

5 Days
§40.163 Verification Window

The MRO has up to 5 business days to verify a non-negative result from the date of collection. This window exists to allow the employee adequate time to provide medical documentation. For urgent safety-sensitive situations, the MRO may provide a preliminary report within 24–48 hours.

CCF
Collector's Role in MRO Review

The MRO reviews the Federal Custody and Control Form (CCF) alongside the laboratory result. A flawless CCF protects the MRO review from challenge. CCF errors are the leading reason MROs flag collections for investigation or cancellation — which is why §40.33 training starts with the CCF.

The MRO Review Process — Step by Step

The DOT drug testing process begins with the collector and ends with the MRO's verified result. Every step is federally prescribed — and the quality of the collector's work at Step 1 directly affects what the MRO can and cannot certify at Step 6.

1

Certified DOT Collector Performs the Collection

A §40.33-certified collector conducts the urine specimen collection following the DOT collection procedure. The collector completes the Federal Custody and Control Form (CCF) — every field, every signature, every checkmark. The CCF documents chain of custody from the point of collection to the laboratory.

49 CFR §40.33 / §40.61–§40.103
2

Primary Specimen Shipped to SAMHSA-Certified Lab

The sealed primary specimen (Bottle A) is shipped to a SAMHSA-certified laboratory. Only laboratories certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) under HHS guidelines are authorized to perform DOT drug testing. The employer does not select the lab — the collection site or C/TPA directs the specimen.

49 CFR §40.81 / §40.83
3

Lab Analyzes Specimen and Reports to MRO

The laboratory analyzes the specimen and transmits results directly to the MRO — not to the employer, not to the DER. The lab reports what its analysis found: the substance detected (if any), the concentration, and any specimen validity findings (substitution, adulteration, or invalidity). The employer has no access to raw laboratory results.

49 CFR §40.127 / §40.129
4

MRO Reviews Lab Result and CCF Documentation

The MRO reviews both the laboratory result and the CCF copy transmitted by the lab. The MRO checks the CCF for fatal flaws and correctable errors, verifies the specimen ID numbers match, and determines whether the result requires employee contact. A negative result with a clean CCF may proceed directly to Step 6.

49 CFR §40.125 / §40.127
5

MRO Contacts Employee for Medical Explanation Interview

For any non-negative result — positive, substituted, adulterated, or invalid — the MRO must contact the employee directly to conduct a medical interview (§40.137). The employee has the opportunity to present a legitimate medical explanation: a valid prescription, a documented medical condition, or other clinical evidence. The employer is not present for this interview.

49 CFR §40.133 / §40.137
6

MRO Issues Final Verified Result to DER

After completing the medical review, the MRO issues a final verified result — Negative, Positive, Substituted, Adulterated, or Invalid — to the Designated Employer Representative (DER). If the result is positive and no valid medical explanation exists, the employer initiates removal from safety-sensitive duties and the SAP referral process begins.

49 CFR §40.163 / §40.165

MRO Qualifications Under 49 CFR §40.121

Not every physician can serve as a DOT MRO. Section 40.121 establishes strict qualification requirements — and just as importantly, disqualifying conditions. Understanding who can be an MRO also clarifies what the MRO role is not: it is not an employer function, it is not a collector function, and it is not a role that can be filled by a non-physician clinician.

MRO Must BeMRO Cannot Be
Licensed physician (MD or DO) with a current and unrestricted licenseA nurse practitioner, physician assistant, or registered nurse — regardless of clinical experience
Must complete DOT MRO training from a qualified provider and pass a written examinationAn employer, DER, or anyone who has supervisory authority over the employee being tested
Must demonstrate knowledge of §40.121 through §40.165 and all applicable HHS guidelinesA certified DOT collector — §40.33 (collector) and §40.121 (MRO) are separate, non-overlapping roles
Must complete continuing education to maintain MRO knowledge current with regulatory changesAn employee of the testing laboratory that analyzed the specimen

The 5 MRO Result Outcomes

Every DOT drug test ends with one of five possible MRO-verified results. These outcomes are defined in 49 CFR Part 40 — no other result category exists under the federal framework. Understanding each outcome matters for HR professionals managing employee returns, for CDL drivers evaluating their options, and for collectors understanding what their documentation must support.

Result 1

Negative

Specimen meets all specimen validity criteria and no prohibited substance was detected at or above the DOT cutoff levels. The employee is cleared to perform safety-sensitive duties without restriction.

Result 2

Positive

One or more prohibited substances were confirmed at or above DOT cutoff levels by GC/MS (or LC/MS/MS) and the MRO found no valid medical explanation. The employee is immediately disqualified from safety-sensitive functions and must be referred to a SAP.

Result 3

Substituted

Creatinine concentration is less than 2 mg/dL and specific gravity is less than 1.001 or greater than 1.020 — physiologically inconsistent with normal human urine. Treated as a refusal to test in most circumstances (§40.191).

Result 4

Adulterated

The specimen contains a substance not expected in normal human urine, or the pH is outside the range of 3.0 to 11.0 — indicating an attempt to interfere with testing. Treated as a refusal to test (§40.191).

Result 5

Invalid

The specimen produces results outside reportable parameters — it cannot be tested or the results cannot be interpreted. Under §40.159, an invalid result requires the MRO to order an immediate recollection under direct observation. The invalid specimen is not reported as a positive or refusal.

“A flawless CCF is the collector's job.”

CCF errors are the #1 reason MROs flag collections for investigation. A missing collector signature, a wrong specimen ID number, an unchecked split specimen box, or an unexplained temperature reading can trigger MRO inquiry — and in the worst case, force cancellation of an otherwise valid result. Protecting the MRO review starts with the collector.

How the MRO and Collector Interact

The MRO and the collector rarely interact in real time — but when they do, it matters significantly. Section 40.133 authorizes the MRO to contact the collector directly when a CCF documentation issue requires clarification. This is not a routine quality check; it is a regulatory mechanism triggered when the CCF contains an error the MRO needs resolved before issuing a final result.

§40.133 — The Collector's Obligations to the MRO

  • §40.133(a): If the MRO contacts you with a question about a CCF, you must respond within 24 hours — there is no grace period.
  • The MRO may ask for clarification of a missing signature, a discrepant remark, or an ambiguous notation on the CCF.
  • Your response allows the MRO to issue a corrected document (if the error is correctable) rather than cancelling the collection.
  • If the error is a §40.199 fatal flaw — such as a missing collector signature with no corrective affidavit — the MRO may have no choice but to cancel the result.

Common CCF Errors That Trigger MRO Inquiry

Missing Collector Signature

Fatal flaw under §40.199(b) — result may be cancelled if no corrective affidavit can be obtained within the MRO's verification window.

Wrong Specimen ID Number

CCF and specimen bottle ID mismatch creates a chain-of-custody break — MRO cannot certify specimen identity without collector clarification.

Unchecked Split Specimen Box

If Copy 1 doesn't document that a split specimen was collected, the employee may not be able to exercise their §40.171 split specimen retest rights.

Temperature Out of Range — No Remark

A temperature outside 90–100°F (§40.91) without a collector remark or alternate temperature documentation triggers specimen validity questions.

The training connection: §40.33 certification covers every CCF field — exactly what MROs look for. Cedar & Crown's course includes a dedicated CCF module that walks through each copy of the form, every required notation, and the documentation standards MROs use to evaluate collector quality.

The Split Specimen Process — §40.171

When a DOT drug test produces a non-negative verified result, the employee has a federally protected right to request that the split specimen — Bottle B — be tested at a second SAMHSA-certified laboratory. This right exists to protect employees from laboratory error, and the entire split specimen framework hinges on the collector correctly sealing both bottles at the point of collection.

Employee's Right — §40.171

  • Employee must request split specimen test within 72 hours of MRO notification of the non-negative result.
  • The MRO must honor this request and arrange shipment of Bottle B to a second SAMHSA-certified laboratory.
  • The employee is responsible for the cost of the split specimen test unless the employer agrees to pay.

Split Specimen Outcomes

  • Reconfirmed: split specimen confirms the original result — positive stands, SAP process continues.
  • Fails to reconfirm: MRO reports the result as cancelled; an immediate recollection under direct observation is required.
  • No split available: if the collector failed to seal Bottle B correctly (§40.83), the employee loses split specimen rights — collector error directly harms the employee.

Collector's Obligation — §40.83

Section 40.83 requires the collector to collect both the primary (Bottle A) and split (Bottle B) specimens at the point of collection and seal them correctly before the donor leaves the collection area. Bottle B must contain a minimum of 15 mL. Failure to collect, fill, or properly seal Bottle B is a fatal collection error — and it eliminates the employee's right to challenge a positive result. This is a core topic on the §40.33 proficiency examination.

MRO vs. SAP — Two Distinct Federal Roles

The MRO and the Substance Abuse Professional (SAP) are both federally required roles in the DOT drug testing process — but they operate at different points in the timeline and serve entirely different functions. Confusing them is a common source of misunderstanding among HR professionals and CDL drivers.

MRO — Medical Review OfficerSAP — Substance Abuse Professional
Reviews laboratory results and verifies the outcome of a drug testEvaluates the employee after a confirmed violation and determines treatment needs
Authority: 49 CFR §40.121–§40.165Authority: 49 CFR §40.281–§40.311
Verifies the test outcome — was there a prohibited substance at a DOT cutoff?Prescribes education and/or treatment to address the substance use violation
Involved before a confirmed violation is reported to the employerInvolved after the violation is confirmed — triggers the return-to-duty process
Must be a licensed physician (MD or DO) — no other credential qualifiesMay be a licensed physician, psychologist, social worker, EAP professional, or certified counselor

Learn more: What Is a DOT SAP?

Train to the Standard MROs Expect — Get §40.33 Certified

Every MRO review traces back to the collection. Learn the CCF, the collection procedure, and the documentation standards MROs enforce — all in Cedar & Crown's $99 bilingual course.

Start §40.33 Certification — $99

Frequently Asked Questions — DOT MRO

Can the employer contact the MRO directly?+
No. Under §40.129, the MRO reports verified results to the Designated Employer Representative (DER) — the employer cannot initiate contact with the MRO or attempt to direct MRO decisions. The MRO operates independently to protect the integrity of the verification process. An employer who attempts to influence an MRO's determination may violate federal regulations.
How long does MRO review take?+
Under §40.163, the MRO has up to 5 business days to verify a non-negative result from the date of specimen collection. For urgent situations involving safety-sensitive removal, the MRO may report a preliminary result to the DER within 24–48 hours. Routine negative results are typically transmitted to the DER by the laboratory directly on the MRO's behalf, usually within 2–3 business days.
What happens if the MRO can't reach the employee?+
Under §40.133(c), the MRO must make at least two contact attempts using the phone numbers provided by the employer. If the MRO cannot reach the employee, the MRO may contact the DER to help locate the employee. If there is still no response within 10 business days of the MRO's first contact attempt, the MRO reports the result as a positive or refusal — the employee's failure to respond does not delay or cancel the verification.
Can the MRO cancel a positive result?+
Yes, under limited conditions. The MRO can cancel a positive result if the employee provides a legitimate medical explanation — for example, a valid prescription for a medication that accounts for the confirmed substance. The MRO can also cancel a result due to a collector error that cannot be corrected through a statement of correction. This is precisely why accurate CCF documentation by the collector is so critical.
Is the MRO required for non-DOT drug tests?+
No. MRO review under 49 CFR Part 40 is mandatory only for DOT-regulated employers conducting federally mandated testing under one of the six DOT modal agencies. Non-DOT employers conducting workplace drug testing under state law or private policy may voluntarily use a Medical Review Officer, but it is not federally required outside the Part 40 framework.

Certified Collectors Make the MRO's Job Easier — And Their Own Livelihood More Secure

Every MRO review traces back to the collection. A complete, accurate CCF is the difference between a result that stands and one that gets flagged, cancelled, or challenged. §40.33 certification teaches every CCF field, every collection step, and every documentation requirement MROs expect. Cedar & Crown's bilingual course is built on the same §40 standards MROs enforce — so collectors enter the field prepared for exactly what the review process demands.

Start §40.33 Certification — $99
También disponible en español: ¿Qué Es un MRO en las Pruebas de Drogas DOT?